Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accrual, added, aim, allocate, allocation, AMGEVITA, argument, automated, Cadila, Canada, challenging, cholesterol, Citigroup, cognition, cognitive, composite, composition, dealer, dermatology, disagree, disposed, Drexel, earned, function, Hamilton, heard, heart, Herceptin, injection, inter, introduced, IRS, Johnston, Larson, leave, lipoprotein, lived, Lori, maximally, Mizuho, Morgan, OCM, Ohio, oncology, optimized, overhaul, oversee, percent, physician, reform, relevant, residual, rheumatology, simpler, small, solid, statin, structure, substantive, Suisse, suit, sweeping, taxation, test, Teva, thereof, TOWER, Trademark, Trump, underway, unpatentable, unrepatriated, Ventura
Removed:
achieved, acquire, aggregated, America, antibody, Asia, aspect, assumed, BLA, cholesteryl, chronic, commencing, conform, construction, continued, decline, deduction, direct, dyslipidemia, East, ester, etelcalcetide, Europe, exercise, expired, Florida, forma, fracture, fully, funding, hearing, hypothetical, inhibitor, Jersey, KAI, Kingdom, largely, Latin, licensure, Mateo, mentioned, Middle, movement, Northern, oral, Parsabiv, partner, pathway, payable, pediatric, perform, Pfizer, postmenopausal, pound, principally, Pro, production, protein, Retacrit, retrospectively, romosozumab, San, Southern, supplementary, transition, UCB, vesting, wholesaler, withholding, women, Zarxio
Filing tables
Filing exhibits
Related press release
AMGN similar filings
Filing view
External links